OPR - Delayed Quote • USD BIO Jun 2024 290.000 put (BIO240621P00290000) Follow 22.10 +0.95 (+4.49%) As of April 26 at 1:56 PM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for BIO240621P00290000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: BIO Bio-Rad Announces Life Science Group Management Changes New Strong Sell Stocks for April 19th Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits? Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53% Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition OncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ... Q4 2023 OncoCyte Corp Earnings Call Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay Waters (WAT) Boosts Waters Operating Segment With HPLC System Bio-Rad’s Chief Operating Officer Andrew Last to Retire Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
